Thrombotic Thrombocytopenic Purpura (TTP)
NHS England - Specialised Commissioning · Awarded
- Buyer
- NHS England - Specialised Commissioning
- Status
- Awarded
- Country
- United Kingdom
- Region
- England
- Sector
- Professional Services
- Reference
- FaT-ocds-h6vhtk-029113
- Published
- 2021-02-08
Tender summary
Thrombotic Thrombocytopenic Purpura (TTP) is a serious blood disorder that results in blood clots forming in small blood vessels throughout the body. It affects the kidneys, heart and brain. If a patient is treated outside a specialist centre, mortality is 50%; in a specialist centre, it is 20%. There is also an appreciable acute morbidity, particularly in neurological disorders. The condition can be difficult to diagnose because initial presentation can be non-specific. Rapid treatment is essential for optimal outcomes and includes plasma exchange and a range of drugs. This disease primarily…
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access